Serina Therapeutics, Inc.SERNYSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+103.7%
5Y CAGR+20.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+103.7%/yr
vs -29.2%/yr prior
5Y CAGR
+20.6%/yr
Recent acceleration
Acceleration
+132.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.6x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $23.43M | +38.6% |
| 2024 | $16.91M | +173.1% |
| 2023 | $6.19M | +123.5% |
| 2022 | $2.77M | -40.7% |
| 2021 | $4.67M | -49.1% |
| 2020 | $9.18M | -30.9% |
| 2019 | $13.29M | +20.8% |
| 2018 | $11.00M | +20.4% |
| 2017 | $9.14M | -32.3% |
| 2016 | $13.49M | - |